Notch and PI3K/Akt/mTOR also contribute to the development of OS, and the inhibitors targeting PI3K, Akt, mTOR or Notch signaling demonstrates robust suppression on the proliferation of OS cells in vitro and the OS tumor growth in vivo [15, 22, 52]. This evidence concerns the gene AKT1 and neoplasm.